Forschungsprojekte
Ergebnisse pro Seite:
10
2024 - 2022
A Randomized Open Label Phase 1/2 Study of INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared To Daratumumab SC, in Participants With Relapsed or Refractory Multiple Myeloma- Dr. med. Markus Munder,
- Prof. Dr. med. Georg Heß
2024
Wissenschaftliche Begleitung der Einführung von Schulgesundheitsfachkräften an Grundschulen in Rheinland-Pfalz 2024 (QUINDI)- Dr. med. univ. Michael Eichinger,
- Prof. Dr. Michael Urschitz
2024 - 2026
Development of a KRASG12V targeting TCRmimic-bispecific T cell engager (BiTE) to improve immunotherapy in non-small cell lung cancer (NSCLC)- Benedikt J. Lohnes,
- PD Dr. Udo F. Hartwig
2024 - 2031
CAR-T-Zell-Behandlung für unbehandeltes Hochrisiko-MANtle-Zell-Lymphom (#1462)- Dr. Eva Wagner-Drouet
2024 - 2029
International Registery of the HIT-HGG Study Group for Pediatric Patients and Young Adults with High Grade Glioma- Univ.-Prof. Dr. med. Jörg Faber